Shagun Singh
Stock Analyst at RBC Capital
(2.60)
# 2,278
Out of 5,050 analysts
238
Total ratings
51.76%
Success rate
-0.14%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Outperform | $365 → $370 | $318.70 | +16.10% | 3 | Nov 7, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $88 → $92 | $83.53 | +10.14% | 6 | Nov 7, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $211 → $202 | $176.70 | +14.32% | 3 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $111 → $101 | $88.74 | +13.82% | 17 | Nov 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $81.78 | +52.85% | 7 | Nov 4, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $89 → $95 | $83.56 | +13.69% | 23 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Outperform | $100 → $85 | $54.87 | +54.91% | 5 | Oct 31, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $615 → $625 | $561.83 | +11.24% | 17 | Oct 22, 2025 | |
| ABT Abbott Laboratories | Reiterates: Outperform | $147 | $125.94 | +16.72% | 17 | Oct 16, 2025 | |
| BSX Boston Scientific | Reiterates: Outperform | $125 | $99.93 | +25.09% | 17 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $22 | $12.06 | +82.42% | 13 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $16.21 | +54.23% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $130 → $135 | $109.22 | +23.60% | 22 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $268.10 | +21.22% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $185 | $186.70 | -0.91% | 22 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.05 | +185.71% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $101 | $91.86 | +9.95% | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $356.36 | +22.07% | 19 | Jan 29, 2025 |
Insulet
Nov 7, 2025
Maintains: Outperform
Price Target: $365 → $370
Current: $318.70
Upside: +16.10%
Globus Medical
Nov 7, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $83.53
Upside: +10.14%
Becton, Dickinson and Company
Nov 7, 2025
Maintains: Sector Perform
Price Target: $211 → $202
Current: $176.70
Upside: +14.32%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $88.74
Upside: +13.82%
Inspire Medical Systems
Nov 4, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $81.78
Upside: +52.85%
Edwards Lifesciences
Oct 31, 2025
Maintains: Outperform
Price Target: $89 → $95
Current: $83.56
Upside: +13.69%
DexCom
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $54.87
Upside: +54.91%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $615 → $625
Current: $561.83
Upside: +11.24%
Abbott Laboratories
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $125.94
Upside: +16.72%
Boston Scientific
Sep 29, 2025
Reiterates: Outperform
Price Target: $125
Current: $99.93
Upside: +25.09%
Aug 19, 2025
Reiterates: Sector Perform
Price Target: $22
Current: $12.06
Upside: +82.42%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $16.21
Upside: +54.23%
Aug 1, 2025
Maintains: Sector Perform
Price Target: $130 → $135
Current: $109.22
Upside: +23.60%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $268.10
Upside: +21.22%
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $186.70
Upside: -0.91%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.05
Upside: +185.71%
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $91.86
Upside: +9.95%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $356.36
Upside: +22.07%